// App-Quantinova.ai

3249 : Regulation of interferon regulatory factor-8 (IRF8) during myelopoiesis is a critical checkpoint for the formation of defective myeloid cells in cancer

Researchers

Presenter

  • Colleen S. Netherby

Principal Investigators

  • Michelle N. Messmer

  • Scott I. Abrams

Medical Centers

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Colony stimulating factor 1

  • Glomeruloid microvascular proliferation

  • Granulocyte colony-stimulating factor

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Interferon

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved